Brief: Pediapharm reports Q4 net loss of $1.4 mln
June 28 (Reuters) - Pediapharm Inc PDP.V
* Pediapharm announces annual audited financial results,
enters first full year with 3 additional products
* Q4 revenue rose 155 percent to c$1.659 million
* Qtrly net loss was $1.4 million versus a net profit of
$1.54 million
Source text for Eikon: ID:nCCNYzHJ5a
Further company coverage: PDP.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million